SWTX logo

SpringWorks Therapeutics (SWTX) Free cash flow

annual FCF:

-$196.30M+$33.88M(+14.72%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SWTX annual free cash flow is -$196.30 million, with the most recent change of +$33.88 million (+14.72%) on December 31, 2024.
  • During the last 3 years, SWTX annual FCF has fallen by -$66.41 million (-51.12%).
  • SWTX annual FCF is now -1257.63% below its all-time high of -$14.46 million, reached on December 31, 2018.

Performance

SWTX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

quarterly FCF:

-$68.79M-$33.24M(-93.49%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX quarterly free cash flow is -$68.79 million, with the most recent change of -$33.24 million (-93.49%) on March 31, 2025.
  • Over the past year, SWTX quarterly FCF has increased by +$10.72 million (+13.48%).
  • SWTX quarterly FCF is now -558.23% below its all-time high of $15.01 million, reached on December 31, 2020.

Performance

SWTX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

TTM FCF:

-$185.58M+$10.72M(+5.46%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX TTM free cash flow is -$185.58 million, with the most recent change of +$10.72 million (+5.46%) on March 31, 2025.
  • Over the past year, SWTX TTM FCF has increased by +$59.31 million (+24.22%).
  • SWTX TTM FCF is now -2395.05% below its all-time high of -$7.44 million, reached on March 31, 2019.

Performance

SWTX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

SWTX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.7%+13.5%+24.2%
3 y3 years-51.1%-34.7%-16.1%
5 y5 years-308.0%-315.4%-207.9%

SWTX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-51.1%+14.7%-197.4%+13.5%-13.4%+25.2%
5 y5-year-497.9%+14.7%-558.2%+13.5%-465.2%+25.2%
alltimeall time-1257.6%+14.7%-558.2%+13.5%-2395.1%+25.2%

SWTX Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$68.79M(+93.5%)
-$185.58M(-5.5%)
Dec 2024
-$196.30M(-14.7%)
-$35.55M(+30.6%)
-$196.30M(-11.2%)
Sep 2024
-
-$27.23M(-49.6%)
-$221.15M(-10.8%)
Jun 2024
-
-$54.02M(-32.1%)
-$248.01M(+1.3%)
Mar 2024
-
-$79.51M(+31.6%)
-$244.89M(+6.4%)
Dec 2023
-$230.18M(+34.0%)
-$60.40M(+11.7%)
-$230.18M(+2.0%)
Sep 2023
-
-$54.08M(+6.3%)
-$225.73M(+15.9%)
Jun 2023
-
-$50.90M(-21.4%)
-$194.78M(+5.0%)
Mar 2023
-
-$64.80M(+15.8%)
-$185.48M(+8.0%)
Dec 2022
-$171.76M(+32.2%)
-$55.96M(+141.9%)
-$171.76M(+5.0%)
Sep 2022
-
-$23.13M(-44.4%)
-$163.62M(-2.5%)
Jun 2022
-
-$41.60M(-18.6%)
-$167.75M(+5.0%)
Mar 2022
-
-$51.08M(+6.8%)
-$159.82M(+23.0%)
DateAnnualQuarterlyTTM
Dec 2021
-$129.89M(+295.6%)
-$47.82M(+75.4%)
-$129.89M(+93.7%)
Sep 2021
-
-$27.26M(-19.0%)
-$67.06M(+22.7%)
Jun 2021
-
-$33.66M(+59.2%)
-$54.66M(+46.1%)
Mar 2021
-
-$21.15M(-240.9%)
-$37.42M(+14.0%)
Dec 2020
-$32.83M(-31.8%)
$15.01M(-201.0%)
-$32.83M(-48.7%)
Sep 2020
-
-$14.87M(-9.5%)
-$63.95M(+6.1%)
Jun 2020
-
-$16.42M(-0.8%)
-$60.28M(+5.3%)
Mar 2020
-
-$16.56M(+2.8%)
-$57.23M(+19.0%)
Dec 2019
-$48.11M(+232.8%)
-$16.10M(+43.8%)
-$48.11M(+50.3%)
Sep 2019
-
-$11.20M(-16.3%)
-$32.01M(+53.8%)
Jun 2019
-
-$13.38M(+79.8%)
-$20.81M(+179.8%)
Mar 2019
-
-$7.44M
-$7.44M
Dec 2018
-$14.46M
-
-

FAQ

  • What is SpringWorks Therapeutics annual free cash flow?
  • What is the all time high annual FCF for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics annual FCF year-on-year change?
  • What is SpringWorks Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics quarterly FCF year-on-year change?
  • What is SpringWorks Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics TTM FCF year-on-year change?

What is SpringWorks Therapeutics annual free cash flow?

The current annual FCF of SWTX is -$196.30M

What is the all time high annual FCF for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high annual free cash flow is -$14.46M

What is SpringWorks Therapeutics annual FCF year-on-year change?

Over the past year, SWTX annual free cash flow has changed by +$33.88M (+14.72%)

What is SpringWorks Therapeutics quarterly free cash flow?

The current quarterly FCF of SWTX is -$68.79M

What is the all time high quarterly FCF for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high quarterly free cash flow is $15.01M

What is SpringWorks Therapeutics quarterly FCF year-on-year change?

Over the past year, SWTX quarterly free cash flow has changed by +$10.72M (+13.48%)

What is SpringWorks Therapeutics TTM free cash flow?

The current TTM FCF of SWTX is -$185.58M

What is the all time high TTM FCF for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high TTM free cash flow is -$7.44M

What is SpringWorks Therapeutics TTM FCF year-on-year change?

Over the past year, SWTX TTM free cash flow has changed by +$59.31M (+24.22%)
On this page